Robotic mitral valve replacement; results from the world’s largest series

• DOI: 10.21037/acs-2022-rmvs-11
• Publication Date: 2022-09-27T07:50:23Z
• Authors: Gokhan Arslanhan; Sahin Senay; Muharrem Kocyigit; Ahmet Umit Gullu; Cem Alhan
• Keywords: Mitral valve replacement; Stroke

This study evaluates the clinical outcome of patients with robotic mitral valve replacement (MVR).Between January 2010 and April 2022, 117 consecutive underwent MVR or without additional cardiac procedures. All procedures were completed by a single surgical team Da Vinci Robotic Systems. Perioperative variables early outcomes recorded.Mean age EuroScore II 57.1±12.9 5.1±5.7, respectively. Isolated was performed in 55 (47.0%) combined 62 (53.0%) patients. Additional included: ablation for atrial fibrillation, tricuspid replacement, repair, left appendix ligation, patent foramen ovale closure, thrombectomy septal myectomy hypertrophic obstructive cardiomyopathy. Mean cardiopulmonary bypass time cross clamp 143±54 93±37 minutes, intensive care unit stay 26.5±26.0 hours. Postoperative stroke observed one (0.9%) patient new onset renal failure two (1.7%) postoperative mortality three (2.6%) patients, which lower than expected.Robotic is feasible can be good outcomes. A majority require